All Curated Mutation Sites in ZIKV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in ZIKV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
M
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  
FWR
  

Keyword: E
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 37891235 V473M
E
envelope
Zika virus infection
G
R
S
L
View
2 35336887 A310E
E
envelope
Zika virus infection
G
R
L
View
3 35336887 E393K
E
envelope
Zika virus infection
G
R
L
View
4 28539654 L307F
E
envelope
Zika virus infection
R
S
C
L
View
5 28539654 G1898U
E
envelope
Zika virus infection
R
S
C
L
View
6 28539654 A1116G
E
envelope
Zika virus infection
R
S
C
L
View
7 28539654 G1522U
E
envelope
Zika virus infection
R
S
C
L
View
8 28539654 G1820A
E
envelope
Zika virus infection
R
S
C
L
View
9 28539654 G1820C
E
envelope
Zika virus infection
R
S
C
L
View
10 28539654 T337V
E
envelope
Zika virus infection
R
S
C
L
View
11 28539654 G472V
E
envelope
Zika virus infection
R
S
C
L
View
12 28539654 K571K
E
envelope
Zika virus infection
R
S
C
L
View
13 28539654 K571N
E
envelope
Zika virus infection
R
S
C
L
View
14 28539654 L597F
E
envelope
Zika virus infection
R
S
C
L
View
15 39599819 K394A
E
envelope
Guillain-Barre Syndrome
G
C
L
View
16 39599819 N154A
E
envelope
Guillain-Barre Syndrome
G
C
L
View
17 39599819 Q77A
E
envelope
Guillain-Barre Syndrome
G
C
L
View
18 39599819 D67N
E
envelope
Guillain-Barre Syndrome
G
C
L
View
19 39599819 A69T
E
envelope
Guillain-Barre Syndrome
G
C
L
View
20 39561198 A248V
E
envelope
Guillain-Barre Syndrome
G
R
S
L
View
21 39561198 V330L
E
envelope
Guillain-Barre Syndrome
G
R
S
L
View
22 34327243 E143K
E
envelope
Cell line
G
R
View
23 34327243 R3394K
E
envelope
Cell line
G
R
View
24 30886357 K316Q
E
envelope
Cell line
S
View
25 30886357 S461G
E
envelope
Cell line
S
View
26 30886357 Q350L
E
envelope
Cell line
S
View
27 30886357 T397S
E
envelope
Cell line
S
View
28 36271143 S455L
E
envelope
Cell line
R
L
T
View
29 28174309 346delA
E
envelope
Cell line
View
30 28174309 Q350I
E
envelope
Cell line
View
31 28174309 T351V
E
envelope
Cell line
View
32 34282707 G282A
E
envelope
Cell line
R
T
View
33 32842538 N69Q
E
envelope
Cell line
G
L
View
34 31757867 E393D
E
envelope
Cell line
G
I
L
View
35 33753816 D4W
E
envelope
Cell line
G
R
L
View
36 32747564 V473M
E
envelope
Cell line
G
S
L
View
37 36367083 V763M
E
envelope
Cell line
G
R
S
C
L
View
38 31138647 A264C
E
envelope
Cell line
G
R
View
39 31547297 N154A
E
envelope
Cell line
G
View
40 39412258 C2178T
E
envelope
Cell line
R
S
View
41 39412258 H401Y
E
envelope
Cell line
R
S
View
42 39412258 T1435A
E
envelope
Cell line
R
S
View
43 39412258 V153D
E
envelope
Cell line
R
S
View
44 30845254 G150E
E
envelope
Cell line
View
45 30845254 V391A
E
envelope
Cell line
View
46 30845254 346del
E
envelope
Cell line
I
View
47 40291117 N154A
E
envelope
Cell line
D
R
T
View
48 40291117 N154D
E
envelope
Cell line
D
R
I
T
View
49 40291117 V153D
E
envelope
Cell line
D
R
I
T
View
50 35575481 G100A
E
envelope
Cell line
I
View
51 35575481 L107A
E
envelope
Cell line
I
View
52 35575481 E162A
E
envelope
Cell line
I
View
53 35575481 G182A
E
envelope
Cell line
I
View
54 35575481 K301A
E
envelope
Cell line
I
View
55 35575481 G302A
E
envelope
Cell line
I
View
56 35575481 T309A
E
envelope
Cell line
I
View
57 35575481 I317A
E
envelope
Cell line
I
View
58 35575481 T335A
E
envelope
Cell line
I
View
59 35575481 G337A
E
envelope
Cell line
I
View
60 35575481 S368A
E
envelope
Cell line
I
View
61 35575481 T369A
E
envelope
Cell line
I
View
62 35575481 E370A
E
envelope
Cell line
I
View
63 35575481 T397A
E
envelope
Cell line
I
View
64 35575481 H398A
E
envelope
Cell line
I
View
65 35575481 H399A
E
envelope
Cell line
I
View
66 30763872 V330L
E
envelope
Cell line
L
View
67 32747564 M473V
E
envelope
Cell line
L
View
68 35793354 F108A
E
envelope
Cell line
I
L
T
View
69 35234632 D67N
E
envelope
Cell line
R
S
View
70 35234632 M68I
E
envelope
Cell line
R
S
View
71 31238493 I152T
E
envelope
Cell line
R
I
View
72 31238493 T156I
E
envelope
Cell line
R
I
View
73 31238493 H158Y
E
envelope
Cell line
R
I
View
74 29091758 N154Q
E
envelope
Cell line
R
View
75 32796074 V330L
E
envelope
Cell line
S
View
76 31043537 S368R
E
envelope
Cell line
R
S
I
L
View
77 30144463 C2178T
E
envelope
Cell line
G
R
L
View
78 30144463 H401Y
E
envelope
Cell line
G
R
L
View
79 36968111 V355I
E
envelope
Cell line
View
80 33910950 S304F
E
envelope
Cell line
R
S
L
View
81 34757841 V114M
E
envelope
Cell line
R
L
View
82 36968111 V335I
E
envelope
Cell line
View
83 31882898 C1616T
E
envelope
Cell line
R
L
View
84 31882898 C2375T
E
envelope
Cell line
R
L
View
85 31809512 D393E
E
envelope

G
R
L
View
86 31809512 T487M
E
envelope

G
R
L
View
87 31809512 V473M
E
envelope

G
R
L
View
88 31809512 V330K
E
envelope

G
R
L
View
89 36910181 I317V
E
envelope

R
View
90 36910181 E393D
E
envelope

R
View
Contents
Description

The table shows all curated mutation sites of ZIKV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.